Stepan Company (SCL) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.
Total Assets Chart for Stepan Company
Stepan Company (SCL) total assets for FY2025 were USD 2.4B, a 2.3% change from FY2024. Stepan Company's total assets grew from USD 139.3M in 1985 to USD 2.4B in 2025 (1592.5% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 6.1%, 10-year CAGR of 6.6%, 20-year CAGR of 7.9%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.45B
- Implied Share Price
- $63.91
- Enterprise Value
- $2.04B
- Revenue (TTM)
- $2.43B
- EBITDA
- $209.64M
- Profit Margin
- -0.11%
- Trailing P/E
- —
- Forward P/E
- 17.45
- Price/Book (MRQ)
- 1.21
- Price/Sales (TTM)
- 0.60
- EV/EBITDA
- 8.98
- EV/Revenue
- 0.84
- Dividend Yield
- 2.44%
- Book Value
- $53.32
- Free Cash Flow (FY2025)
- $25.37M
- Free Cash Flow Yield
- 1.75%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.